Herbal cancer cure claims
This article was originally published in The Tan Sheet
Executive Summary
David Walker, d/b/a DLW Consulting, permanently barred from representing dietary supple-ments, devices as "effective in treating and curing cancer" or as making "surgery, chemotherapy and other conventional cancer treatments unnecessary" absent competent and reliable scientific evidence, according to stipulated judgment signed by Tacoma, Wash. federal judge Oct. 23. In case brought by FTC, Walker also is required to turn over to commission customers' names, addresses; judgment includes monetary penalty if Walker made "material misrepresentations or omissions" in his financial disclosure form. FTC sued Walker in March related to cancer claims for CWAT-Treatment: BioResonance Therapy, which included dietary supplements (1"The Tan Sheet" April 8, 2002, p. 14). 2FTC press release notes Walker was required to pay $229,000 in consumer restitution under companion case brought by Washington AG...
You may also be interested in...
Herbal Cancer Cure One Of 63 Scams Targeted By FTC Internet Initiative
FTC's heightened focus on Internet fraud is reflected in a spate of 63 law enforcement actions the commission filed targeting deceitful Internet claims and/or deceptive spam (unsolicited commercial email.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.